60 Degrees Pharmaceuticals (SXTP) Minority Interest (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Minority Interest of -$84702.0 for Q1 2026, down 4.13% year-over-year from -$88346.8 in Q1 2025, and down 1.12% quarter-over-quarter from -$83761.0 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Minority Interest (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Minority Interest for 5 consecutive years, with -$84702.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Minority Interest fell 4.13% year-over-year to -$84702.0; the TTM figure through Mar 2026 stood at -$84702.0 (down 4.13% YoY), while the FY2025 annual figure was -$83761.0, down 3.93% from the prior year.
- Minority Interest slipped to -$84702.0 in Q1 2026 per SXTP's latest filing, from -$83761.0 in the prior quarter.
- Across five years, Minority Interest topped out at -$38105.0 in Q3 2023 and bottomed at -$576829.0 in Q2 2023.
- Historically, Minority Interest has averaged -$152517.8 across 5 years, with a median of -$81346.0 in 2025.
- Annual changes were most pronounced in 2023 — Minority Interest soared 87.41% — and 2024, when it slumped 101.3%.
- 60 Degrees Pharmaceuticals' Minority Interest stood at -$572320.0 in 2022, then jumped by 87.41% to -$72038.0 in 2023, then slipped by 11.88% to -$80594.0 in 2024, then dropped by 3.93% to -$83761.0 in 2025, then decreased by 1.12% to -$84702.0 in 2026.
- Business Quant data shows SXTP's Minority Interest at -$84702.0 in Q1 2026, -$83761.0 in Q4 2025, and -$83262.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84,702.00 |
| Dec 31, 2025 | -83,761.00 |
| Sep 30, 2025 | -83,262.00 |
| Jun 30, 2025 | -82,550.00 |
| Mar 31, 2025 | -81,346.00 |
| Dec 31, 2024 | -80,594.00 |
| Sep 30, 2024 | -76,707.00 |
| Jun 30, 2024 | -75,994.00 |
| Mar 31, 2024 | -74,523.00 |
| Dec 31, 2023 | -72,038.00 |
| Sep 30, 2023 | -38,105.00 |
| Jun 30, 2023 | -576,829.00 |
| Dec 31, 2022 | -572,320.00 |